Risperdal Consta Priced Aggressively; J&J Sets High Premium To Zyprexa
Executive Summary
Johnson & Johnson's Risperdal Consta (risperidone) is being launched at approximately twice the daily cost of Lilly's market-leading antipsychotic Zyprexa (olanzapine)
You may also be interested in...
Risperdal Consta Reimbursement Is Question Of “When, Not If” – Alkermes
Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs
Risperdal Consta Reimbursement Is Question Of “When, Not If” – Alkermes
Alkermes is confident that Risperdal Consta will ultimately be reimbursed by all 50 state Medicaid programs
J&J Antipsychotic Paliperidone ER Moves Into Phase III
Johnson & Johnson has moved a potential successor compound to the antipsychotic Risperdal into Phase III clinical studies